Description
An antibiotic with antimycobacterial activity; an irreversible inhibitor of DprE1; active against M. tuberculosis in vitro (MIC = ≤0.19 ng/ml) without inducing cytotoxicity in Vero cells at 125 µM; reduces the bacterial burden in the lung and spleen in a mouse model of chronic tuberculosis at 50 mg/kg per day
Formal name: 2-[4-(cyclohexylmethyl)-1-piperazinyl]-8-nitro-6-(trifluoromethyl)-4H-1,3-benzothiazin-4-one
Synonyms:
Molecular weight: 456.5
CAS: 1377239-83-2
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antibiotics||Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Bacterial Diseases|Tuberculosis